Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

41.07
+0.08000.20%
Volume:3K
Turnover:111.99K
Market Cap:204.53M
PE:- -
High:41.07
Open:41.00
Low:40.97
Close:40.99
52wk High:47.00
52wk Low:29.28
Shares:4.98M
Float Shares:4.98M
Volume Ratio:0.77
T/O Rate:0.05%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly - Aims to Treat Equal Number of Patients in Lmics and High-Income Countries by 2040

THOMSON REUTERS
·
Sep 28

Coiled Therapeutics Director Increases Stake as Precision Oncology Pipeline Advances

TIPRANKS
·
Sep 28

JPMorgan Adjusts Price Target on Eli Lilly to $1,500 From $1,400, Maintains Overweight Rating

MT Newswires Live
·
Sep 28

Eli Lilly's Olumiant Gets FDA Approval for Severe Alopecia Areata in Adolescents

MT Newswires Live
·
Sep 28

Nektar selloff on trial brings ‘strong entry point,’ says BTIG

TIPRANKS
·
Sep 28

Eli Lilly Gets Expanded Label Approval from FDA for Alopecia Drug

Dow Jones
·
Sep 26

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

THOMSON REUTERS
·
Sep 26

Top Midday Stories: Akamai's $11.6 Billion Anthropic Deal; Scholastic Q1 Loss Widens; Nektar Awarded $90 Million in Eli Lilly Case

MT Newswires Live
·
Sep 26

Sector Update: Healthcare Stocks Edge Higher Premarket Friday

MT Newswires Live
·
Sep 25

Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance

Deep News
·
Sep 25

Legend Biotech Says Five-Year Carvykti Data Show 50% of Patients Remained Progression-Free and Alive

MT Newswires Live
·
Sep 25

Legend Biotech Reports Five-Year CARVYKTI Survival Data in Earlier-Line Myeloma

TIPRANKS
·
Sep 25

Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing

THOMSON REUTERS
·
Sep 25

Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares

Reuters
·
Sep 25

Legend Biotech Shareholders Back Board Slate and Expand Equity Plan at 2026 AGM

TIPRANKS
·
Sep 25

Legend Biotech Shareholders Voted at Annual General Meeting

Reuters
·
Sep 25

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 25

Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis

TradingKey
·
Sep 24

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

Reuters
·
Sep 24

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
Sep 24